4月30日,百济神州宣布,美国专利商标局(USPTO)作出了一项最终书面决定,宣布艾伯维旗下Pharmacyclics LLC在专利授权后复审(PGR)程序中受到百济神州质疑的第11672803号美国专利(‘803专利)的全部权利无效。Pharmacyclics可对USPTO的最终书面决定提出上诉。该诉讼经过如下:2023年6月15日,Pharmacyclics指控百济神州BTK抑制剂百悦泽(泽布...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.